U083 Medical Problems with Cosmetic Overtones
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Patients often see a dermatologist for cosmetic concerns, but sometimes these may have an etiology which is medically necessary to address. Additionally, there are many skin conditions that are cosmetically concerning and medically necessary to treat. There are also medical problems for which treatment modalities traditionally used in cosmetic dermatology are appropriate.
LEARNING OBJECTIVES
Choose the best treatment modality to address conditions with medical/cosmetic overlap
Identify the appropriate diagnostic workup necessary to evaluate cosmetic concerns
SCHEDULE
8:30 PM
Introduction
Raheel Zubair, MHS, MD, FAAD
8:35 PM
Treating Acne and Acne Scars
Anne M. Chapas, MD, FAAD
8:45 PM
Use of Fillers, Fat Transfer, and Neuromodulators for Medical Problems
Kimberly J. Butterwick, MD, FAAD
8:55 PM
Laser Treatment of Medical Problems
Douglas Wu, MD, PhD, FAAD
9:05 PM
Laser Treatment of Scars
Jill S. Waibel, MD, FAAD
9:15 PM
Q&A
SPEAKERS
Kimberly J. Butterwick, MD, FAAD
Anne M. Chapas, MD, FAAD
Jill S. Waibel, MD, FAAD
Douglas Wu, MD, PhD, FAAD
Raheel Zubair, MHS, MD, FAAD
SPEAKER DISCLOSURES
Kimberly J. Butterwick, MD, FAAD
Allergan, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Evolus, Inc. – Advisory Board(Honoraria); Merz Pharmaceuticals, LLC – Advisory Board(Honoraria); Neutrogena Corporation – Advisory Board(Honoraria); Revance Therapeutics, Inc. – Advisory Board(Honoraria); Suneva Medical, Inc. – Advisory Board(Honoraria);
Anne M. Chapas, MD, FAAD
Allergan, Inc – Speaker/Faculty Education(Honoraria); Cytrellis Biosystems, Inc – Speaker(Honoraria); Evolus, Inc. – Speaker(Honoraria); InMode MD Ltd – Investigator(Grants/Research Funding); Lumenis – Investigator(Grants/Research Funding); lutronic – Speaker(Honoraria); Revance – Investigator(Grants/Research Funding); reveance – Investigator(Grants/Research Funding); sofwave – Speaker(Honoraria); Solta Medical – Speaker(Honoraria); Syneron Candela – Advisory Board(Honoraria);
Jill S. Waibel, MD, FAAD
Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);
Douglas Wu, MD, PhD, FAAD
Allergan, Inc. – Speaker/Faculty Education(Honoraria); Galderma USA – Speaker/Faculty Education(Honoraria); Syneron Candela – Consultant(Honoraria);
Raheel Zubair, MHS, MD, FAAD
Avita Medical – Investigator(Grants/Research Funding);